Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

Brief Summary

Background: In perioperative period inhibition of N-Methyl-D-Aspartate receptor prevents opioid-induced hyperalgesia and reduce postoperative opioid requirement after abdominal surgery. Methadone is both a µ-opioid receptor agonist like Morphine and a N-Methyl-D-Aspartate antagonist. Study Aim. To evaluate the efficacy of intraoperative Ketamine and postoperative Methadone analgesia in preventing opioid-induced hyperalgesia after abdominal surgery.

Intervention / Treatment

  • Drug: ketamine infusion
  • Drug: Methadone PCA

Condition or Disease

  • Post Operative Pain
  • Hyperalgesia

Phase

Study Design

Study type: Interventional
Status: Unknown status
Study results: No Results Available
Age: 18 Years to 75 Years   (Adult, Older Adult)
Enrollment: 96 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Dec 09, 2020
Primary Completion: Jun 12, 2020
Completion Date: Aug 12, 2020
Study First Posted: May 08, 2012
Results First Posted: Aug 31, 2020
Last Updated: May 16, 2012

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

not desired

Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 75

More Details

NCT Number: NCT01594047
Other IDs: metadone
Study URL: https://ClinicalTrials.gov/show/NCT01594047
Last updated: Jun 17, 2022